A Study of Evacetrapib (LY2484595) in Healthy Participants

Summary

The purpose of this study is to measure and compare the amounts of the study drug evacetrapib found in the blood after taking two different formulations. The study has 3 periods. Participants will take each formulation by mouth at least once. A minimum of 14 days will pass between study drug doses. The safety and tolerability of the study drug will also be examined. Information about any side effects that may occur will also be collected. This study will last approximately 6 weeks.

Timeline

Start

2013-07

Primary completion

2013-11

Completion

2013-11

Drugs

Indications

No indication recorded.